Clinical Trial: A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity

U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06974851) titled 'A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity' on April 24.

Brief Summary: A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects with Obstructive Sleep Apnea (OSA) and Obesity

Study Start Date: May, 2025

Study Type: INTERVENTIONAL

Condition: Bstructive Sleep Apnea (OSA) and Obesity

Intervention: DRUG: HRS9531

HRS9531

DRUG: HRS9531placebo

HRS9531placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.

Published by HT Digital Content Services with permission from Healt...